Product Information
ERYTHROMYCIN-BENZOYL GEL is a generic product labeled by Oceanside Pharmaceuticals, priced at $0.9375 per GM under NDC 68682090146. Its NADAC has been published 539 times since Jun 10, 2015.
FDA first approved this application on Oct 26, 1984. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Oceanside PharmaceuticalsNDC
68682090146
Classification
Generic
Dosage Form
KIT
Effective Date
9/17/2025
Approval Type
Authorized Generic (NDA)
FDA Application
NDA050557FDA Approved
10/26/1984
TE Code
AB
On Market Since
10/26/1984
Price Statistics
The NADAC for ERYTHROMYCIN-BENZOYL GEL has been published 539 times since Jun 10, 2015, and over the history we have for it it has risen 24.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9375 per GM |
|---|---|
| All-time high | $6.5537 (Nov 11, 2015) |
| All-time low | $0.7100 (Jul 17, 2024) |
| Median price | $1.8288 |
| Average price | $2.4099 |
| Largest weekly change | +334.9% (Aug 19, 2015) |
| Weeks tracked | 539 |
| Tracking since | Jun 10, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+18.2%
5Y
-27.5%
All
+24.5%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythromycin and Benzoyl Peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN-BENZOYL GEL?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN-BENZOYL GEL, manufactured by Oceanside Pharmaceuticals, is $0.9375 per GM (NDC 68682090146), effective Oct 1, 2025.
How has the price of ERYTHROMYCIN-BENZOYL GEL changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN-BENZOYL GEL has risen 24.5%. It has been tracked across 539 weekly CMS publications since Jun 10, 2015.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN-BENZOYL GEL?
Since Jun 10, 2015, the NADAC for ERYTHROMYCIN-BENZOYL GEL has ranged from a low of $0.7100 (Jul 17, 2024) to a high of $6.5537 (Nov 11, 2015), with a median of $1.8288 per GM.
Are there cheaper alternatives to ERYTHROMYCIN-BENZOYL GEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ERYTHROMYCIN-BENZOYL GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures ERYTHROMYCIN-BENZOYL GEL?
ERYTHROMYCIN-BENZOYL GEL (NDC 68682090146) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.